David S H Lee
Biographic Data
| ID | 5540630 |
|---|---|
| NAME | David S H Lee |
| GIVEN NAMES | David S H |
| FAMILY NAME | Lee |
| SIGNATURE | LEE D S H |
| AFFILIATIONS | Department of Pharmacy Practice, College of Pharmacy Oregon State University/Oregon Health & Science University Portland Oregon |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2016 |
| H-INDEX | 0 |
Rural‐Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians
PURPOSE: To characterize disease burden and medication usage in rural and urban adults aged ≥85 years. METHODS: This is a secondary analysis of 5 years of longitudinal data starting in the year 2000 from 3 brain-aging studies. Cohorts consisted of community-dwelling adults: 1 rural cohort, the Klamath Exceptional Aging Project (KEAP), was compared to 2 urban cohorts, the Oregon Brain Aging Study (OBAS) and the Dementia Prevention study (DPS). In …
Effect of β-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
CONTEXT: In older adults with multiple conditions, medications may not impart the same benefits seen in patients who are younger or without multimorbidity. Furthermore, medications given for one condition may adversely affect other outcomes. β-Blocker use with coexisting cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) is such a situation. OBJECTIVE: To determine the effect of β-blocker use on cardiac and pulmonary ou…
No prominent works on this page.
Effect of β-Blockers on Cardiac and Pulmonary Events and Death in Older Adults With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease
CONTEXT: In older adults with multiple conditions, medications may not impart the same benefits seen in patients who are younger or without multimorbidity. Furthermore, medications given for one condition may adversely affect other outcomes. β-Blocker use with coexisting cardiovascular disease (CVD) and chronic obstructive pulmonary disease (COPD) is such a situation. OBJECTIVE: To determine the effect of β-blocker use on cardiac and pulmonary ou…
Rural‐Urban Differences in Chronic Disease and Drug Utilization in Older Oregonians
PURPOSE: To characterize disease burden and medication usage in rural and urban adults aged ≥85 years. METHODS: This is a secondary analysis of 5 years of longitudinal data starting in the year 2000 from 3 brain-aging studies. Cohorts consisted of community-dwelling adults: 1 rural cohort, the Klamath Exceptional Aging Project (KEAP), was compared to 2 urban cohorts, the Oregon Brain Aging Study (OBAS) and the Dementia Prevention study (DPS). In …
Internal Medicine (2 works) · Medicine (2 works) · Population (2 works) · Asthma (1 work) · Cardiac, Anesthesia and Surgical Outcomes (1 work) · Cardiology (1 work) · Chronic Obstructive Pulmonary Disease (COPD) Research (1 work) · Cohort (1 work) · Cohort study (1 work) · Confidence interval (1 work)